Grifols SA (GRFS)

22.77
0.30 1.34
NASDAQ : Health Technology
Prev Close 22.47
Open 22.54
Day Low/High 22.48 / 22.77
52 Wk Low/High 17.24 / 25.18
Volume 266.10K
Avg Volume 454.60K
Exchange NASDAQ
Shares Outstanding 261.43M
Market Cap 18.27B
EPS 0.90
P/E Ratio 44.06
Div & Yield 0.28 (1.25%)

Latest News

Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems Via HL7 Interfaces

Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems Via HL7 Interfaces

Phocus Rx® is Live with Bidirectional Interfaces with Three of the Top Five Hospital Information Systems in the US

Select American Red Cross Blood Donations Screened For Babesia Parasite Using Grifols' Procleix Babesia Assay Under An Investigational New Drug Protocol

Select American Red Cross Blood Donations Screened For Babesia Parasite Using Grifols' Procleix Babesia Assay Under An Investigational New Drug Protocol

- American Red Cross is testing selected donations collected in areas of the U.S. that are endemic for the tick known to carry the Babesia parasite

Grifols Continues To Strengthen Its Diagnostic Division By Launching New Global Testing Services For The Measurement Of Biological Drug Levels And Anti-Drug Immune Response In Blood Samples

Grifols Launches New Therapeutic Drug Monitoring Testing Services for the Biologic Drugs Infliximab, Adalimumab and Vedolizumab

Grifols And Beckman Coulter Enter Into An Exclusive Distribution Agreement

Multi-year agreement advances companies' objectives to provide diagnostics solutions that support and improve patient care

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic and Grifols have worked together since 1998 building a blood screening business, and now Hologic will sell its share to Grifols.

Grifols Immunohematology Center Laboratory In San Marcos, Texas, Has Expanded Its Testing Capabilities To Include Basic And Advanced Serological And Molecular Testing. (Graphic: Business Wire)

Grifols Immunohematology Center Laboratory In San Marcos, Texas, Has Expanded Its Testing Capabilities To Include Basic And Advanced Serological And Molecular Testing. (Graphic: Business Wire)

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a global healthcare company, has expanded the menu of tests offered at the Grifols Immunohematology Center laboratory to include basic and advanced serological and molecular...

5 Big Dividend Stocks Billionaire John Paulson Loves

5 Big Dividend Stocks Billionaire John Paulson Loves

Here's a closer look at five dividend stocks that Paulson & Co. owned in the most recently reported quarter.

3 Stocks Pulling The Health Services Industry Downward

3 Stocks Pulling The Health Services Industry Downward

TheStreet highlights 3 stocks pushing the drugs industry lower today.

3 Stocks Pushing The Health Services Industry Higher

3 Stocks Pushing The Health Services Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Health Services Stocks Driving The Industry Higher

3 Health Services Stocks Driving The Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Weak On High Volume: Grifols (GRFS)

Weak On High Volume: Grifols (GRFS)

Trade-Ideas LLC identified Grifols (GRFS) as a weak on high relative volume candidate

8 Biotech Stocks That Should Be in Your Portfolio Right Now

8 Biotech Stocks That Should Be in Your Portfolio Right Now

Which biotech companies are the best investments for your portfolio? Consider buying any of these eight A+ rated stocks.

3 Stocks Raising The Health Services Industry Higher

3 Stocks Raising The Health Services Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

Grifols (GRFS) Strong On High Relative Volume Today

Grifols (GRFS) Strong On High Relative Volume Today

Trade-Ideas LLC identified Grifols (GRFS) as a strong on high relative volume candidate

Strong On High Relative Volume: Grifols (GRFS)

Strong On High Relative Volume: Grifols (GRFS)

Trade-Ideas LLC identified Grifols (GRFS) as a strong on high relative volume candidate

First Week Of GRFS February 2016 Options Trading

First Week Of GRFS February 2016 Options Trading

Investors in Grifols SA, Barcelona saw new options become available this week, for the February 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 217 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

3 Stocks Advancing The Drugs Industry

3 Stocks Advancing The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Improving Performance Of The Drugs Industry

3 Stocks Improving Performance Of The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Driving The Health Care Sector Higher

3 Stocks Driving The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

4 Stocks Spiking on Unusual Volume: Novo Nordisk and More

4 Stocks Spiking on Unusual Volume: Novo Nordisk and More

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

3 Health Services Stocks Nudging The Industry Higher

3 Health Services Stocks Nudging The Industry Higher

TheStreet highlights 3 stocks pushing the health services industry higher today.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the Health Services industry lower today.

3 Stocks Pushing The Health Care Sector Lower

3 Stocks Pushing The Health Care Sector Lower

TheStreet highlights 3 stocks pushing the Health Care sector lower today.

3 Stocks Raising The Drugs Industry Higher

3 Stocks Raising The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Boosting The Drugs Industry Higher

3 Stocks Boosting The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the Health Services industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

TheStreet Quant Rating: B (Buy)